Full name
The ENDURA-2 Study: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Depemokimab in Adult Participants With COPD With Type 2 Inflammation
NCT Number
NCT06961214
Geography
US
Locations
United States
Primary Endpoints
Annualized Rate of Moderate/Severe Exacerbations. Baseline up to Week 104
Order
2
Disease
Version
Phase
3
Status
Recruiting